skip to Main Content

Post-Licensure Evaluation of the Long-Term Effectiveness of ZOSTAVAX

This study consists of data collection on patients receiving treatment with Prevnar (13vPnC) as part of their standard medical care.

Investigator: Klein, Nicola

Funder: Merck & Company, Inc.

Explore all studies and publications

Back To Top